Search in:

OncoImmunology Volume 8, 2019 - Issue 3

Submit an article Journal homepage

Open access

3,364

Views

CrossRef citations to date

Altmetric

Original Research

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome

Scott D. BrownCanada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada;Genome Science and Technology Program, University of British Columbia, Vancouver, British Columbia, CanadaView further author information

Robert A. HoltCanada’s Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada;Genome Science and Technology Program, University of British Columbia, Vancouver, British Columbia, Canada;Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada;Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, CanadaCorrespondence[email protected]
View further author information

Article: 1556080 | Received 16 Aug 2018, Accepted 27 Nov 2018, Published online: 22 Dec 2018

Cite this article
https://doi.org/10.1080/2162402X.2018.1556080
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Kun Liu, Shengyuan He, Shangqin Sun, Xinxin Zhang, Yanzhen He, Fei Quan, Bo Pang & Yun Xiao. (2023) Computational Quantification of Cancer Immunoediting. Cancer Immunology Research 11:9, pages 1159-1167.
Crossref

Choong-kun Lee, Sun Young Rha, Hyo Song Kim, Minkyu Jung, Beodeul Kang, Jingmin Che, Woo Sun Kwon, Sejung Park, Woo Kyun Bae, Dong-Hoe Koo, Su-Jin Shin, Hyunki Kim, Hei-Cheul Jeung, Dae Young Zang, Sang Kil Lee, Chung Mo Nam & Hyun Cheol Chung. (2022) A single arm phase Ib/II trial of first-line pembrolizumab, trastuzumab and chemotherapy for advanced HER2-positive gastric cancer. Nature Communications 13:1.
Crossref

Wenwen Wang, Tinggan Yuan, Lili Ma, Yanjing Zhu, Jinxia Bao, Xiaofang Zhao, Yan Zhao, Yali Zong, Yani Zhang, Shuai Yang, Xinyao Qiu, Siyun Shen, Rui Wu, Tong Wu, Hongyang Wang, Dong Gao, Peng Wang & Lei Chen. (2022) Hepatobiliary Tumor Organoids Reveal HLA Class I Neoantigen Landscape and Antitumoral Activity of Neoantigen Peptide Enhanced with Immune Checkpoint Inhibitors. Advanced Science 9:22.
Crossref

Seema Khadirnaikar, Annesha Chatterjee, Pranjal Kumar & Sudhanshu Shukla. (2020) A Greedy Algorithm-Based Stem Cell LncRNA Signature Identifies a Novel Subgroup of Lung Adenocarcinoma Patients With Poor Prognosis. Frontiers in Oncology 10.
Crossref

Cesare Gridelli, Tudor Ciuleanu, Manuel Domine, Aleksandra Szczesna, Isabel Bover, Manuel Cobo, Nikolaos Kentepozidis, Konstantinos Zarogoulidis, Charalabos Kalofonos, Andrzej Kazarnowisz, Magdalena Korozan, Ramon de las Penas, Margarita Majem, Antonio Chella, Frank Griesinger, Evangelos Bournakis, Parvis Sadjadian, Athanasios Kotsakis, Thierry Chinet, Kostantinos N. Syrigos, Pierpaolo Correale, Catherine Gallou, Jeanne- Menez Jamet, Eleni- Kyriaki Vetsika, Kostas Kosmatopoulos & Vassilis Georgoulias. (2020) Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial. British Journal of Cancer 122:10, pages 1461-1466.
Crossref

Hans-Peter Gerber, Leah V. Sibener, Luke J. Lee & Marvin H. Gee. (2020) Identification of Antigenic Targets. Trends in Cancer 6:4, pages 299-318.
Crossref

Michael Ghosh, Marion Gauger, Ana Marcu, Annika Nelde, Monika Denk, Heiko Schuster, Hans-Georg Rammensee & Stefan Stevanović. (2020) Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies. Molecular & Cellular Proteomics 19:3, pages 432-443.
Crossref

Wei Yang, Yanyan Li, Ruoling Gao, Zenghe Xiu & Ting Sun. (2019) MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway. Oncogene 39:5, pages 1098-1111.
Crossref

Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part B. Tumor Immunology and Immunotherapy – Integrated Methods Part B xvii xxxvi .

Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Integrated Methods Part A. Tumor Immunology and Immunotherapy – Integrated Methods Part A xix xxxviii .

Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part B. Tumor Immunology and Immunotherapy – Cellular Methods Part B xxiii xlii .

Lorenzo Galluzzi & Nils-Petter Rudqvist. 2020. Tumor Immunology and Immunotherapy – Cellular Methods Part A. Tumor Immunology and Immunotherapy – Cellular Methods Part A xxiii xlii .

Lorenzo Galluzzi & Nils-Petter Rudqvist. 2019. Tumor Immunology and Immunotherapy – Molecular Methods. Tumor Immunology and Immunotherapy – Molecular Methods xxi xl .

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date